FDA Works With Manufacturers to Increase Menopause Patch Availability Amidst Demand Surge
The Food and Drug Administration is collaborating with manufacturers to boost the availability of menopause patches in response to increased demand and existing supply shortages.
Seattle Tacoma, WA, September 4, 2026 —
The U.S. Food and Drug Administration (FDA) is actively engaged in cooperative efforts with pharmaceutical manufacturers to address a growing demand for menopause patches. This initiative aims to significantly enhance the availability of these hormone therapy products, which are crucial for managing menopausal symptoms for many individuals.
The collaboration comes in direct response to observed increases in patient demand for menopause patches, coupled with pre-existing challenges in the supply chain. These supply shortages have reportedly impacted the accessibility of the medication, leading to concern among healthcare providers and patients alike.
Hormone therapy patches deliver estrogen and, in some cases, progestin, through the skin to alleviate symptoms such as hot flashes, night sweats, and vaginal dryness associated with menopause. The FDA’s role in this situation involves working closely with the companies that produce these patches to identify and overcome obstacles to production and distribution.
The specifics of the collaboration, including any timelines for increased production or the names of specific manufacturers involved, were not detailed. However, the agency’s stated objective is to ensure that patients can continue to access needed treatments without interruption. The FDA continually monitors the supply of critical medications and works with industry partners to mitigate shortages.
This partnership underscores the agency’s commitment to public health by proactively addressing potential disruptions in essential pharmaceutical supplies. The focus remains on improving the supply of menopause patches to meet current and future patient needs, thereby supporting the well-being of individuals experiencing menopause.
Story summarized from the original created by Daniel.Miller@fox.com (Daniel Miller) on www.fox13seattle.com, see more information here.
